These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2878713)

  • 1. Post-mortem neurochemical changes in Alzheimer's disease compared with normal ageing.
    Rossor M; Mountjoy CQ
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):499-502. PubMed ID: 2878713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological markers in mental disorders: post-mortem studies.
    Rossor M
    J Psychiatr Res; 1984; 18(4):457-65. PubMed ID: 6150994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cholinergic system in old age and Alzheimer's disease.
    Perry EK
    Age Ageing; 1980 Feb; 9(1):1-8. PubMed ID: 7361631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
    Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurotransmitter anomalies in Alzheimer's disease].
    Berger B
    Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides in the neocortex in Alzheimer's disease and ageing.
    Ferrier IN; Leake A
    Psychoneuroendocrinology; 1990; 15(2):89-95. PubMed ID: 1972799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits.
    Beal MF; Mazurek MF; Ellison DW; Kowall NW; Solomon PR; Pendlebury WW
    Neuroscience; 1989; 29(2):339-46. PubMed ID: 2566953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alzheimer's type dementia: recent data].
    Lamour Y; Davous P
    Presse Med; 1983 May; 12(22):1415-20. PubMed ID: 6134279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.
    Flynn DD; Mash DC
    J Neurochem; 1986 Dec; 47(6):1948-54. PubMed ID: 3772387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
    Aisa B; Gil-Bea FJ; Solas M; García-Alloza M; Chen CP; Lai MK; Francis PT; Ramírez MJ
    J Alzheimers Dis; 2010; 20(2):659-68. PubMed ID: 20164549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
    Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED
    J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptides in Alzheimer's disease: a postmortem study.
    Nemeroff CB; Kizer JS; Reynolds GP; Bissette G
    Regul Pept; 1989 Apr; 25(1):123-30. PubMed ID: 2566190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
    Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease.
    Greenwood AF; Powers RE; Jope RS
    Neuroscience; 1995 Nov; 69(1):125-38. PubMed ID: 8637611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease.
    Sorbi S; Piacentini S; Amaducci L
    Gerontology; 1987; 33(3-4):197-202. PubMed ID: 3653702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
    Francis PT; Palmer AM; Sims NR; Bowen DM; Davison AN; Esiri MM; Neary D; Snowden JS; Wilcock GK
    N Engl J Med; 1985 Jul; 313(1):7-11. PubMed ID: 2582256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
    Reinikainen KJ; Soininen H; Riekkinen PJ
    J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal pattern of labeling of cerebral cortical corticotropin-releasing factor (CRF) receptors in Alzheimer's disease: evidence from chemical cross-linking studies.
    Grigoriadis DE; Struble RG; Price DL; De Souza EB
    Neuropharmacology; 1989 Jul; 28(7):761-4. PubMed ID: 2548115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
    Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
    Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.